A client who receives levetiracetam should be closely monitored for which symptom?

A. Angioedema: Levetiracetam is not commonly associated with angioedema. This reaction is more often linked to ACE inhibitors or certain antibiotics, making it less relevant for this medication. B. Psychosis: Although mood and behavior changes may occur with levetiracetam, psychosis is not a primary adverse effect requiring close monitoring. The more significant concern is mood disturbances leading to self-harm. C. Suicidal ideation: Levetiracetam has been associated with increased risk of depression, agitation, and suicidal thoughts or behaviors. Clients should be closely monitored for mood changes and suicidal ideation during therapy. D. Oliguria: Levetiracetam is excreted renally, but oliguria is not a typical adverse effect. While dose adjustments may be needed in renal impairment, reduced urine output is not a common symptom requiring routine monitoring.